Quarterly report pursuant to Section 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/LOSS (Parenthetical)
CONDENSED CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Notes to Financial Statements
General
Summary of Significant Accounting Policies
Revenue
Profit/(loss) per share
Accumulated other comprehensive (loss)/income
Fair value measurements
Marketable securities - available-for-sale debt securities
Other current assets
Operating leases
Accrued expenses and other current liabilities
Share-based compensation
Stockholders' equity
Business combinations
Borrowings
Segment Reporting
Inventories
Subsequent events
Pay vs Performance Disclosure
Insider Trading Arrangements
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Revenue (Tables)
Profit/(loss) per share (Tables)
Accumulated other comprehensive (loss)/income (Tables)
Fair value measurements (Tables)
Marketable securities - available-for-sale debt securities (Tables)
Other current assets (Tables)
Operating leases (Tables)
Accrued expenses and other current liabilities (Tables)
Share-based compensation (Tables)
Business combinations (Tables)
Borrowings (Tables)
Segment Reporting (Tables)
Inventories (Table)
Notes Details
General (Details)
Summary of Significant Accounting Policies - Cash, cash equivalents and restricted cash (Details)
Summary of Significant Accounting Policies - Accounts receivable (Details)
Revenue - Revenue from contracts with customers (Details)
Revenue - Galapagos Collaboration (Details)
Revenue - Collaboration Agreement - The Genentech Collaboration and License Agreement (Details)
Revenue - Collaboration Agreement - The GSK Termination and Transfer Agreement (Details)
Revenue - Collaboration Agreement - The Astellas Collaboration Agreement (Details)
Profit/(loss) per share - Basic and diluted loss per share (Details)
Profit/(loss) per share - Antidilutive shares (Details)
Accumulated other comprehensive (loss)/income (Details)
Fair value measurements (Details)
Marketable securities - Available-for-sale debt securities (Details)
Marketable securities - Available-for-sale debt securities - Unrealized loss position (Details)
Other current assets (Details)
Operating leases (Details)
Operating leases - Maturities (Details)
Accrued expenses and other current liabilities (Details)
Share-based compensation - Share-based Compensation Expense (Details)
Share-based compensation - Options (Details)
Stockholders equity - Offerings (Details)
Business combinations (Details)
Business combinations - Gain on bargain purchase (Details)
Business combinations - Proforma Information (Details)
Business combinations - Acquisition-related costs (Details)
Borrowings - Narrative (Details)
Borrowings - Maturity (Details)
Segment reporting (Details)
Inventories (Details)
Subsequent events (Details)
Accrued expenses and other current liabilities (Details)
403 Forbidden
Forbidden
You don't have permission to access this resource.